GATC Biotech demonstrates new DNA sequencing capability and sequences 9 bacterial genomes in April

08-May-2007

GATC Biotech has announced that its scientists sequenced nine bacterial genomes in April, demonstrating the capabilities of the Company's technology portfolio and expertise in successful next-generation, high throughput genome sequencing.

GATC Biotech sequenced four gram-positive and five gram-negative genomes from genomic DNA, to produce genome coverage from 15-fold to 30-fold, with a genome size of 3-5 Mb, depending on the genome. The genomes were sequenced for several customers, from within industry and academia, and these initial results will be used to drive the individual customer's research and development programme by sequencing and comparing the optimised strains.

Part of GATC Biotech's contribution to these genome projects was de novo sequencing of the organisms, while part was re-sequencing projects.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances